News

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...